Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AMIN A YEHYA

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1376720946
CMS profile
153507
Location
NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$44,621.92

92 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme LLC $34,558.67 30
Novo Nordisk Inc $4,832.97 5
CVRx, Inc. $2,760.89 12
Abbott Laboratories $1,986.33 38
Alnylam Pharmaceuticals Inc. $179.20 2
Nuwellis, Inc. $136.64 3
Vifor Pharma, Inc. $126.62 1
ABIOMED $40.60 1

Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

AMIN A YEHYA

NPI 1376720946 · CMS profile ID 153507

Allopathic & Osteopathic Physicians / Internal Medicine / Advanced Heart Failure and Transplant Cardiology

NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1376720946?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
AMIN A YEHYA, NPI 1376720946, CMS profile ID 153507. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1376720946?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). AMIN A YEHYA, NPI 1376720946, CMS profile ID 153507. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1376720946?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
AMIN A YEHYA, NPI 1376720946, CMS profile ID 153507, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1376720946?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

92 matching records · $44,621.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 92 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–92 of 92.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $8.3010/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018038283 CMS
Abbott Laboratories $8.3010/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018038295 CMS
Abbott Laboratories $18.1010/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018038353 CMS
Abbott Laboratories $8.3010/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018038585 CMS
Abbott Laboratories $9.0710/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018044139 CMS
Alnylam Pharmaceuticals Inc. $58.2309/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006128269 CMS
Merck Sharp & Dohme LLC $96.4809/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449899 CMS
Merck Sharp & Dohme LLC $212.3609/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048784141 CMS
Merck Sharp & Dohme LLC $202.5709/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048874551 CMS
Vifor Pharma, Inc. $126.6208/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1013148529 CMS
ABIOMED $40.6008/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044893853 CMS
Merck Sharp & Dohme LLC $150.0006/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048784345 CMS
Abbott Laboratories $11.7806/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019812437 CMS
Novo Nordisk Inc $91.6206/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003007049 CMS
Merck Sharp & Dohme LLC $4,270.0005/31/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449639 CMS
Merck Sharp & Dohme LLC $150.0005/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048782187 CMS
Novo Nordisk Inc $45.4505/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003007025 CMS
Merck Sharp & Dohme LLC $91.7604/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449667 CMS
Merck Sharp & Dohme LLC $150.0004/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048489271 CMS
Merck Sharp & Dohme LLC $6,710.0004/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048489273 CMS
Merck Sharp & Dohme LLC $65.0003/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048512931 CMS
Merck Sharp & Dohme LLC $50.0003/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048512933 CMS
Merck Sharp & Dohme LLC $86.6703/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048512935 CMS
Merck Sharp & Dohme LLC $55.0003/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048512939 CMS
Merck Sharp & Dohme LLC $328.8103/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048512831 CMS
Merck Sharp & Dohme LLC $357.8103/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048512937 CMS
Merck Sharp & Dohme LLC $199.0003/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048803113 CMS
Merck Sharp & Dohme LLC $4,270.0003/24/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449643 CMS
Alnylam Pharmaceuticals Inc. $120.9703/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006128069 CMS
Merck Sharp & Dohme LLC $3,050.0003/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048784349 CMS
Merck Sharp & Dohme LLC $658.0302/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449353 CMS
Merck Sharp & Dohme LLC $90.0602/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449663 CMS
Abbott Laboratories $157.6402/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019810415 CMS
CVRx, Inc. $159.0902/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058740885 CMS
CVRx, Inc. $179.0002/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058740889 CMS
Merck Sharp & Dohme LLC $150.0001/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048782183 CMS
Merck Sharp & Dohme LLC $4,270.0001/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449349 CMS
Merck Sharp & Dohme LLC $89.3101/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048874549 CMS
Merck Sharp & Dohme LLC $3,050.0001/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449385 CMS
Merck Sharp & Dohme LLC $336.9501/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449345 CMS
Merck Sharp & Dohme LLC $392.0201/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449377 CMS
Merck Sharp & Dohme LLC $522.8401/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048449389 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $37,261.02 78
PY2020 $31,041.76 43
PY2021 $25,634.36 27
PY2022 $47,420.95 49
PY2023 $44,621.92 92
PY2024 $71,892.65 72
PY2025 $140,000.39 135

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $83,532.50 30
PY2024 Principal investigator $32,254.01 19
PY2023 Principal investigator $45,569.10 11
PY2022 Principal investigator $48,698.40 16
PY2021 Principal investigator $16,068.00 4
PY2020 Principal investigator $4.50 1
PY2019 Principal investigator $18,726.60 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

30 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,770.00 10/16/2025 Non-covered Recipient Entity
Sentara Hospitals
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LV No dispute reported 06/30/2026 1225414264
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,234.00 10/08/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419177
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $611.80 10/08/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
Confirmation Study #22563 No dispute reported 06/30/2026 1225420149
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $660.80 09/08/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419373
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $560.00 09/08/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
Confirmation Study #22563 No dispute reported 06/30/2026 1225420055
Principal investigator 1 Nuwellis, Inc. $878.40 09/05/2025 Non-covered Recipient Entity
WCG IRB LLC.
Reverse No dispute reported 06/30/2026 1163223052
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $462.00 08/29/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
Confirmation Study #22563 No dispute reported 06/30/2026 1225420187
Principal investigator 1 Nuwellis, Inc. $1,006.00 08/22/2025 Non-covered Recipient Entity
WCG IRB LLC.
Reverse No dispute reported 06/30/2026 1163223040
Principal investigator 1 Nuwellis, Inc. $169.00 08/22/2025 Non-covered Recipient Entity
WCG IRB LLC.
Reverse No dispute reported 06/30/2026 1163223044
Principal investigator 1 Nuwellis, Inc. $1,433.00 08/08/2025 Non-covered Recipient Entity
WCG IRB LLC.
Reverse No dispute reported 06/30/2026 1163223038
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,982.40 08/05/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419635
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $10,591.00 08/04/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
Confirmation Study #22563 No dispute reported 06/30/2026 1225420103
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $12,486.00 07/31/2025 Non-covered Recipient Entity
Sentara Hospitals
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LV No dispute reported 06/30/2026 1225413390
Principal investigator 1 Nuwellis, Inc. $2,406.50 07/25/2025 Non-covered Recipient Entity
WCG IRB LLC.
Reverse No dispute reported 06/30/2026 1163223026
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $6,701.00 07/22/2025 Non-covered Recipient Entity
Sentara Hospitals
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LV No dispute reported 06/30/2026 1225413266
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,021.60 07/09/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419291
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $590.80 06/02/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419191
Principal investigator 1 Nuwellis, Inc. $101.00 05/09/2025 Non-covered Recipient Entity
WCG IRB LLC.
Reverse No dispute reported 06/30/2026 1163223024
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,639.40 05/06/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419565
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,035.00 04/30/2025 Non-covered Recipient Entity
Sentara Hospitals
BAY 948862, A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fracti No dispute reported 06/30/2026 1225404229
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,990.00 04/28/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419647
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,025.40 04/07/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225418995
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $12,880.00 03/31/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
Confirmation Study #22563 No dispute reported 06/30/2026 1225419931
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $660.80 03/11/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419579
Principal investigator 1 Nuwellis, Inc. $5,240.00 02/21/2025 Non-covered Recipient Entity
Sentara Norfolk General Hospital
Reverse No dispute reported 06/30/2026 1163222993
Principal investigator 1 Nuwellis, Inc. $800.00 02/14/2025 Non-covered Recipient Entity
Sentara Norfolk General Hospital
Reverse No dispute reported 06/30/2026 1163222991
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,321.60 02/10/2025 Non-covered Recipient Entity
Sentara Hospitals Outpatient Pharmacy
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419383
Principal investigator 1 Nuwellis, Inc. $2,100.00 02/07/2025 Non-covered Recipient Entity
Sentara Norfolk General Hospital
Reverse No dispute reported 06/30/2026 1163222989
Principal investigator 1 Nuwellis, Inc. $1,725.00 01/29/2025 Non-covered Recipient Entity
Sentara Norfolk General Hospital
Reverse No dispute reported 06/30/2026 1163222987
Principal investigator 1 Nuwellis, Inc. $2,450.00 01/24/2025 Non-covered Recipient Entity
Sentara Norfolk General Hospital
Reverse No dispute reported 06/30/2026 1163222985